BRAF, BRAF V600E, BRAF V600E mutation, CD34, DNT, DNTs, FGFR1, FGFR1/2/3, FGRF1, GG, GG MC, GG MC MC, GNT, LEATs, LGG, Low, Low-grade epilepsy-associated neuroepithelial tumours, MAPK, NTRK2, PLGG, PLGG NOS, RNA, V600E, central nervous system (CNS) tumours, dysembryoplastic neuroepithelial tumours, fibroblast growth factor receptor 1, fusion transcript, ganglioglioma, glioneuronal tumours, haematopoietic progenitor cell antigen, low-grade epilepsy-associated neuroepithelial tumours, mitogen-activated protein kinase, murine, neurotrophic tyrosine kinase receptor type 2, oligodendroglioma, paediatric-type low-grade glioma, polymorphous low-grade neuroepithelial tumour, tumours, tyrosine, v-Raf murine sarcoma viral oncogene homologue B, with